UNSPSC 51391715: Dipivefrin or dipivefrine

This classification denotes an anti-glaucoma agent with the molecular formula C19H29NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8Q1PVL543G, chemically known as 4-(1-hydroxy-2-(methylamino)ethyl)-1,2-phenylen dipivalat but generally known as dipivefrin, which bears US NIH Compound Identifier 3105. European Medicines Agency schedules Dipivefrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07217MIG.

UNSPSC 51391715 Dipivefrin or dipivefrine is a Commodity code that captures pharmaceutical products, though recent state and local opportunities tagged under it show a significant mismatch — the posted solicitations are for naloxone and drug deactivation systems, and a market-intelligence RFI on direct-to-manufacturer prescription programs, neither of which involve dipivefrin. State and local buyers soliciting under this code are primarily county health departments and state health agencies. Seminole County, Florida has posted procurement activity in this space, and the Texas Health and Human Services Commission is exploring direct pharmacy relationships. The actual buying pattern under the code remains unclear given the misalignment between the code's nominal scope and the posted opportunities.

Recent activity is sparse and geographically scattered. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with a bid deadline of July 26, 2023 and quarterly deliveries required to the Seminole County Community Health Building in Sanford. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026 seeking vendor capabilities for a direct-to-manufacturer prescription program, framed as exploratory market research rather than a formal competitive procurement. The code shows limited recent procurement activity relevant to dipivefrin itself, making evaluation of market opportunity difficult at this time.